These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 6506005)
1. [Evaluation of drug-induced hepatic complications collected by the French drug surveillance organization]. Jean-Pastor MJ; Jouglard J Therapie; 1984; 39(5):493-500. PubMed ID: 6506005 [No Abstract] [Full Text] [Related]
2. [Hepatitis from antidepressants. Evaluation of cases from the French Association of Drug Surveillance Centers and the Technical Committee]. Lefebure B; Castot A; Danan G; Elmalem J; Jean-Pastor MJ; Efthymiou ML Therapie; 1984; 39(5):509-16. PubMed ID: 6506007 [No Abstract] [Full Text] [Related]
3. [Hepatitis during antibiotic therapy. Retrospective evaluation of the Association of Drug Surveillance Centers and the Bureau of Drug Surveillance, Health Office]. Lavarenne J; Dumas R; Maradeix B; Fialip J Therapie; 1984; 39(5):517-22. PubMed ID: 6506008 [No Abstract] [Full Text] [Related]
4. [Ticlopidine and hepatic adverse reactions. Data from the Spanish drug surveillance system]. Carvajal García-Pando A; García Ortega P; Rueda de Castro AM; García del Pozo J Med Clin (Barc); 1999 Apr; 112(14):557-8. PubMed ID: 10363248 [No Abstract] [Full Text] [Related]
7. [Postmarketing survey on the clinical use of cefotiam]. Kitaguchi T; Ebi O Jpn J Antibiot; 1983 Aug; 36(8):2029-52. PubMed ID: 6317911 [TBL] [Abstract][Full Text] [Related]
8. Adverse Drug Reactions Advisory Committee: ADRAC report for 1980. Med J Aust; 1982 May; 1(10):416-9. PubMed ID: 6808324 [No Abstract] [Full Text] [Related]
9. [Drug-induced liver disease: experiences of the Swiss Center for Adverse Drug Effects 1989-1991]. Werth B; Kuhn M; Hartmann K; Kobler E; Reinhart WH Schweiz Med Wochenschr; 1993 Jun; 123(23):1203-6. PubMed ID: 8327867 [TBL] [Abstract][Full Text] [Related]
10. [Hepatotoxicity of drugs. Update of a data bank of hepatic involvement and responsible drugs]. Biour M; Poupon R; Grange JD; Chazouillères O; Levy VG; Bodin F; Cheymol G Gastroenterol Clin Biol; 1990; 14(3):263-77. PubMed ID: 2344912 [No Abstract] [Full Text] [Related]
11. [Hepatotoxicity of drugs. Update of the data bank on hepatic involvement and the responsible drugs]. Biour M; Poupon R; Calmus Y; Grange JD; Lévy VG; Bodin F; Cheymol G Gastroenterol Clin Biol; 1989 Jan; 13(1):80-93. PubMed ID: 2925045 [No Abstract] [Full Text] [Related]
12. [Halothane hepatitis. Possibilities of prevention]. Døssing M; Andreasen B; Ranek L; Johansen SH Ugeskr Laeger; 1982 Feb; 144(7):466-8. PubMed ID: 7080249 [No Abstract] [Full Text] [Related]
13. [Hepatotoxicity of drugs. Update of a data bank of hepatic involvements and responsible drugs]. Biour M; Poupon R; Calmus Y; Grangé JD; Hamel JD; Lévy VG; Bodin F; Cheymol G Gastroenterol Clin Biol; 1988 Jan; 12(1):48-60. PubMed ID: 3350250 [No Abstract] [Full Text] [Related]
14. Rechallenge in drug-induced liver injury: the attractive hazard. Andrade RJ; Robles M; Lucena MI Expert Opin Drug Saf; 2009 Nov; 8(6):709-14. PubMed ID: 19968572 [TBL] [Abstract][Full Text] [Related]
15. Adverse drug reactions in children. Fiechtner H S D J Med; 1994 Sep; 47(9):325. PubMed ID: 7973598 [No Abstract] [Full Text] [Related]
17. Adverse drug reactions: part II. Wooten JM South Med J; 2010 Nov; 103(11):1138-45; quiz 1146-7. PubMed ID: 20890249 [TBL] [Abstract][Full Text] [Related]
19. [Methodology of epidemiological studies in drug hepatotoxicity]. Plomteux G Sem Hop; 1974 Jun; 50(28):1947-52. PubMed ID: 4374747 [No Abstract] [Full Text] [Related]
20. Postmarketing surveillance on side-effects of cefminox sodium (Meicelin). Mayama T; Koyama Y; Sebata K; Tanaka Y; Shirai S; Sakai H Int J Clin Pharmacol Ther; 1995 Mar; 33(3):149-55. PubMed ID: 7599913 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]